TuHURA Biosciences, Inc./NV
HURA· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -81.5% in FY2025
Dr. James Bianco is the CEO of TuHURA Biosciences, Inc./NV and was paid $4.0M in FY2025 (Dec), down 34%.
Pay$100 in the stock at the end of FY23 → $13
Executives2
See all- 1Dr. James BiancoPresident and Chief Executive OfficerFY2025
- 2Dan DearbornChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allTuHURA Biosciences, Inc./NV paid its 2 named executives $5.8M in total in FY2025 (Dec). CEO Dr. James Bianco was paid $4.0M of that.
| Name | |||
|---|---|---|---|
| Dr. James BiancoPresident and Chief Executive Officer | Not disclosed | ||
| Dan DearbornChief Financial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for TuHURA Biosciences, Inc./NV. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board1
See all- Laura JohnsonDirector · 3 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2023).
Activity
Filings4
See all| Proxy statement | DEF 14A | Jul 9, 2026 | FY2025 |
| Annual report | 10-K | Mar 31, 2026 | FY2025 |
| Annual report | 10-K | Mar 31, 2025 | FY2024 |
| Proxy statement | DEF 14A | May 17, 2024 | FY2023 |
